Login / Signup

Efficacy of pharmacological interventions in COVID-19: A network meta-analysis.

Sandhiya SelvarajanAnnuja AnandaradjeSanthosh ShivabasappaDeepthy Melepurakkal SadanandanN Sreekumaran NairMelvin George
Published in: British journal of clinical pharmacology (2022)
In comparison to standard of care, dexamethasone was found to increase clinical recovery and lower mortality; remdesivir was significantly associated with a lower risk of mortality as compared to tocilizumab and higher clinical recovery and shorter time to clinical improvement as compared to hydroxychloroquine and tocilizumab; remdesivir followed by tocilizumab were found to have lesser occurrence of serious adverse events in patients with moderate to severe COVID-19.
Keyphrases